Drugs / IodoCarb®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT01793415 Comparator | Feb → Dec 2013 | myalgic encephalomeyelitis/chronic fatigue syndrome | PharmaLundensis AB | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IodoCarb | “3 g iodinated activated charcoal, IodoCarb(r), daily for 28 +-2 days.” NCT01793415 ↗ |
| Known as | IodoCarb(r) | “3 g iodinated activated charcoal, IodoCarb(r), daily for 28 +-2 days.” NCT01793415 ↗ |
| Modality | Other / unclassified | “iodinated activated charcoal” NCT01793415 ↗ |